thiazolyl blue has been researched along with Nasopharyngeal Carcinoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Dai, BQ; Feng, LC; Jiang, X | 1 |
Chu, QQ; Huang, BJ; Huang, HB; Huang, JL; Huang, TJ; Liu, RY; Peng, LX; Qian, CN; Yang, CF; Yang, GD; Yang, HJ; Zhu, ZY | 1 |
Gan, L; Hu, GQ; Hu, GY; Jiang, JZ; Li, WW; Liu, DB; Long, GX; Mei, Q; Sun, W; Wang, JF | 1 |
Bu, X; Fan, R; Ma, J; Sun, X; Tong, J; Xu, R; Zhao, D | 1 |
4 other study(ies) available for thiazolyl blue and Nasopharyngeal Carcinoma
Article | Year |
---|---|
LncRNA TP73-AS1 regulates miR-495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A.
Topics: Biopsy; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Disease Progression; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Protein Binding; Receptors, Cell Surface; RNA, Long Noncoding; Tetrazolium Salts; Thiazoles | 2021 |
Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Carcinoma; Cell Line; Cisplatin; Colony-Forming Units Assay; Drug Resistance, Neoplasm; Fas Ligand Protein; Fluorescent Antibody Technique; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Luciferases; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; Signal Transduction; Tetrazolium Salts; Thiazoles; Viral Matrix Proteins | 2013 |
Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity.
Topics: Carcinoma; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Coloring Agents; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Humans; Indicators and Reagents; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Pyrazoles; Sulfonamides; Tetrazolium Salts; Thiazoles; Wound Healing | 2014 |
A novel multifunctional nanocomposite C225-conjugated Fe3O4/Ag enhances the sensitivity of nasopharyngeal carcinoma cells to radiotherapy.
Topics: Carcinoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Ferrosoferric Oxide; Humans; Microscopy, Electron, Transmission; Molecular Targeted Therapy; Nanocomposites; Nanotechnology; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiation-Sensitizing Agents; Silver; Tetrazolium Salts; Thiazoles; Time Factors | 2012 |